IRIS
SAVI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2155
NA - Nord America 2131
AS - Asia 942
Totale 5228
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2067
CN - Cina 820
IE - Irlanda 541
UA - Ucraina 415
FI - Finlandia 379
SE - Svezia 360
DE - Germania 236
IT - Italia 133
TR - Turchia 99
CA - Canada 64
GB - Regno Unito 33
BE - Belgio 22
AT - Austria 14
NL - Olanda 13
IN - India 12
KR - Corea 7
IR - Iran 3
FR - Francia 2
RO - Romania 2
BG - Bulgaria 1
ES - Italia 1
HR - Croazia 1
IQ - Iraq 1
LT - Lituania 1
LU - Lussemburgo 1
Totale 5228
Salva come PNG Salva come JPEG
Città #
Dublin 541
Jacksonville 539
Chandler 361
Dearborn 264
Beijing 237
Nanjing 136
Princeton 109
San Mateo 100
Izmir 97
Ann Arbor 72
Toronto 63
Shenyang 53
Helsinki 51
Wilmington 50
Nanchang 49
Kunming 41
Hefei 40
Hebei 38
Boardman 34
Jinan 33
Des Moines 27
Jiaxing 26
Changsha 20
Los Angeles 19
Tianjin 18
Brussels 17
Haikou 13
Norwalk 12
Guangzhou 11
Woodbridge 11
Ningbo 10
Vienna 10
Fremont 9
Fuzhou 9
Monmouth Junction 9
Taizhou 8
Zhengzhou 8
Rockville 7
Augusta 6
Chengdu 6
Florence 6
Leawood 6
Chongqing 5
Hangzhou 5
Seongnam 5
Taiyuan 5
Waanrode 5
Wuhan 5
Baotou 4
Borås 4
Faenza 4
Houston 4
Rome 4
Ashburn 3
Auburn Hills 3
Aversa 3
Bremen 3
Milan 3
Mumbai 3
Parma 3
Rio Saliceto 3
Shaoxing 3
Trieste 3
Ardabil 2
Bacoli 2
Bologna 2
Düsseldorf 2
Ferrara 2
Focsani 2
Grafing 2
Kocaeli 2
Mestre 2
Nanning 2
Napoli 2
Pavia 2
Ponte A Moriano 2
Seattle 2
Seoul 2
Wenzhou 2
Xian 2
Acireale 1
Alghero 1
Amsterdam 1
Arezzo 1
Bascape 1
Bressanone 1
Cagliari 1
Campora 1
Castano Primo 1
Cento 1
Chaoyang 1
Cisternino 1
Como 1
Delhi 1
Enschede 1
Fairfield 1
Fermo 1
Frattamaggiore 1
Gainesville 1
Geislingen an der Steige 1
Totale 3310
Salva come PNG Salva come JPEG
Nome #
Oligonucleotide Ligation Assay (OLA) e mutazioni silenti del gene CFTR: una rara causa di parziale fallimento del test 109
TRAPIANTO COMBINATO FEGATO-RENE CON CROSS-MATCH POSITIVO:CONTROINDICAZIONE O OPPORTUNITÀ? 71
Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: analogies with Alport’s syndrome 71
Fluorescent in situ hybridisation on tissue sections: a quantitative approach with confocal laser scanning microscopy 70
Ruolo dei geni del collagene di tipo IV e dei loro prodotti proteici nelle glomerulopatie umane acquisite 70
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. 69
BRCA-1 status, molecular markers and clinical viariables in breast cancer (BC) patients with high probability of having an inherited cancer predisposing genetic mutation 68
Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: mRNA levels, protein expression and urinary loss 67
Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Workshop study 65
Valutazione del gene COL4A5 e del suo prodotto proteico nelle nefropatie glomerulari acquisite 64
BRCA1 and BRCA2 status in a sample of italian women with early onset breast cancer (EOBC) 64
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study 63
Correlazione fra HLA-DRB1*03 e periaortite cronica: una ipotesi di origine autoimmune 63
Tipizzazione dei polimorfismi dei geni del locus HLA, delle citochine e dei loro recettori nella Fibrosi Retroperitoneale Idiopatica (FRI) 63
Immunological abnormalities in a family with progressive external ophtalmoplegia 61
DUPLICAZIONE DELL DELL’ESONE 13 DEL GENE F8 NEI P ’ESONE PAZIENTI EMOFILICI CON AZIENTI FENO FENOTIPO LIEVE: TIPO LA CASISTICA DELLA REGIONE EMILIA ROMA ROMAGNA GNA 60
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin 59
Human T-cell receptor alpha chain gene during ontogeny 59
BRCA1 and BRCA2 status in a sample of italian women with early onset breast cancer (EOBC) 59
Chronic periaortitis and HLA–DRB1*03: Another clue to an autoimmune origin 59
Malattia di Fabry e linfedema familiare. Descrizione di due casi 58
Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations. 57
Riconoscimento in situ di RNA messaggeri umani specifici mediante microscopia confocale in fluorescenza 56
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 56
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 55
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 55
Mesangio-proliferative glomerulonephritis with prevalent deposits of IgA and histocompatibility antigens 55
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes 55
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 55
Clinical, histopathological and biochemical findings in Fabry's disease. A case report 55
Fabry's Disease with Familial Lymphedema of the Lower Limbs. Case Report and Family Study 55
Febbre Mediterranea Familiare e Sindrome Associata a mutazioni nel recettore TNF-alfa: nuove varianti ed interazioni fra i due geni 54
CORRELAZIONE FRA HLA-DRB1*03 E PERIAORTITE CRONICA: UNA IPOTESI DI ORIGINE AUTOIMMUNE 54
Ruolo dei geni del collageno di tipo 4 nelle glomerulopatie acquisite 54
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. 54
RECIPROCHE IMPLICAZIONI DEL TRAPIANTO DI TESSUTI E DI ORGANI SOLIDI 54
Alport syndrome in Italy. A multicenter screening for COL4A5 gene mutations 54
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. 54
CDC – XM NEGATIVO E RIGETTO IPERACUTO 53
HLA ANTIGENS AND INSULIN DEPENDENT DIABETES MELLITUS. A FAMILY STUDY 53
Genetica della Febbre Mediterranea Familiare in Italia 52
HLA-DR antigens and cardiolipin antibodies in northen Italian systemic erythematosus patients. 52
Febbre Mediterranea Familiare (FMF) e sindrome associata a mutazioni del recettore del TNF-alfa (TRAPS): nuove varianti e cross-talk fra i 2 geni. 52
La tecnica multiplex ligation probe amplification (MLPA) per la determinazione dello stato di portatrice in emofilia. 50
Role of the 4A5 collagen gene and its product in human acquired glomerulopathies 50
Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC) 50
Ulteriori nuove mutazioni sul gene COL4A5 mediante PCR e sequenziamento diretto 50
BRCA1 status. Molecular markers and clinical variables in breast cancer (BC) patients with high probability of having an inherited, cancer-predisposing genetic mutation 50
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations. 48
Male breast cancer (MBC) in Parma province: descriptive epidemiology, molecular markers and clinical variables. 48
Lymphocyte antibody lymphocytolytic interaction (LALI) with special enphasis on HLA 48
L'ANALISI MUTAZIONALE DEL GENE COL4A5 MEDIANTE SEQUENZIAMENTO DIRETTO RENDE POSSIBILE LA DIAGNOSI NELLA QUASI TOTALITA'DEI CASI 48
Sospetta eterogeneità genetica nella Febbre Mediterranea Familiare 47
Patient waiting for kidney transplantation with antibodiea vs previous bone allograft. A case report 47
Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. 46
Production of anti HLA antisera by planned immunisations 46
Missense mutations in the COL4A5 gene in patients with X-linked Alport syndrome 46
HLA-DRB1 e TNF, ma non CFTR, sono fattori di rischio per la colangite sclerosante 46
Mutation scanning of the entire COL4A5 coding sequence in Alport syndrome and genotype-phenotype correlation 46
Association between DR antigens, rheumatoid arthritis with and without features and systemic lupus erythematousus in northern Italy. 45
HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. 45
HLA antigens and IgA mesangial glomerulonephritis 45
Medicina genomica. Prospettive e limiti 44
HLA-DR frequecies in northen Italy 44
Missense mutations in the COL4A5 gene in patients with X-linked Alport Syndrome. 44
What strategy for improving HLA alloimmunization screening in cadaver kidney transplant waiting list? A regional experience (Emilia Romagna-Italy). 44
Rapid and sensitive MLPA approach for identification of deletion carriers in haemophilia 44
Hypergammaglobulinemic purpura of Waldenström. (A report of serologic and immunogenetic studies and long-term follow-up in 18 patients). 44
T-cell receptor beta chain gene rearrangement and expression during human thymic ontogenesis. 44
CORRELAZIONE FRA HLA-DRB1*03 E PERIAORTITE CRONICA: UNA IPOTESI DI ORIGINE AUTOIMMUNE 43
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 43
The presence of posttransplant HLA-specific IgG antibodies detected by immunosorbent assay correlates with specific rejection pathologies. 42
Patient waiting for kidney transplantation with antibodiea vs previous bone allograft. A case report 42
HLA and type 1 diabetes: a prospective study of all new cases diagnosed in Piedmont one year 42
The role of HLA polymorphism in susceptibility to Churg-Strauss syndrome and their influence on disease phenotype 42
Ruolo dei polimorfismi dei geni dei fattori della coagulazione nella glomerulosclerosi focale e segmentaria idiopatica 41
REPORT OF THE ITALIAN MULTICENTER STUDY ON ALPORT SYNDROME 41
Screeniong for B cell specific antisera. Results from region Italy 1 41
Spettro di mutazioni nel gene F8 in pazienti affetti da Emofilia A della Regione Emilia Romagna. 40
Anti HLA antibody evolution in recipients of planned transfusions 40
Il paziente con anticorpi anti HLA 40
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. 39
POlimorfisni dei geni delle citochine e dei loro recettori nella Sindrome di Churg-Strauss 38
TCR beta chian gene ontogeny in human thymus 38
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. 38
PRELIMINARY RESULTS OF DONOR SPECIFIC ANTIBODY(DSA) DETERMINATION BY LUMINEX VS CDC-XM INLIVING AND CADAVERIC KIDNEY TRANSPLANTATION: AREGIONAL EXPERIENCE 37
DUPLICAZIONE DELL DELL’ESONE 13 DEL GENE F8 NEI P ’ESONE PAZIENTI EMOFILICI CON AZIENTI FENO FENOTIPO LIEVE: TIPO LA CASISTICA DELLA REGIONE EMILIA ROMA ROMAGNA GNA 37
Screening del gene COL4A5 mediante sequenziamento diretto in pazienti affetti da Sindrome di Alport 37
Serologic and genetic aspects of HLA DR antigen study 36
Mutation scanning of the entire COL4A5 coding sequence in Alport syndrome and genotype-phenotype correlation. 35
TCR-beta chain gene rearrangement and expression in human T-cell development and leukemia. 35
POSITIVE CROSS-MATCH (XM) BEFORE A COMBINED KIDNEY-LIVER TRANSPLANTATION. A CASE REPORT 35
Studio in CDC dei sieri dei pazienti in lista di attesa per trapianto renale. E' ancora attuale nell'epoca della citofluorimetria? 35
Febbre Mediterranea Familiare : necessità di accesso al test genetico sulla base del parere di un clinico esperto. 35
Similarity of the genetic background in rheumatic diseases between northen patients. 35
Patient waiting for kidney transplantation with antibodies vs previous bone allograft. A case report 35
Preliminary results of donor specific antibody (DSA) determination by Luminex vs CDC-XM in living and cadaveric kidney transplantation: a regional experience 35
Some immunological reactions during chronic treatment with antiepilectic drugs 34
Secondary and Primary Vasculitis Study Group.HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome: 34
Genetica del sistema HLA 33
Totale 4973
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201829 0000 00 00 28712
2018/2019309 78115 767 44 321314011
2019/20201619 24127311823 155180 20925 12011543117
2020/2021757 9113645 1133 735 20861562
2021/2022472 33916 124 7398 222946157
2022/20231593 199145103102 117177 1788 645000
Totale 5234